Detalhe da pesquisa
1.
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells.
Proc Natl Acad Sci U S A
; 112(5): E420-9, 2015 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25605940
2.
Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro.
Hepatology
; 57(5): 1838-46, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23299860
3.
Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.
Int J Mol Sci
; 14(2): 3094-109, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23377018
4.
Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy.
Clin Cancer Res
; 29(1): 40-49, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136304
5.
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines.
Mol Cancer
; 11: 22, 2012 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22515704
6.
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations.
J Transl Med
; 9: 76, 2011 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21609436
7.
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
Clin Immunol
; 136(3): 338-47, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20547105
8.
Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.
J Transl Med
; 8: 39, 2010 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20406486
9.
Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive longterm BRAF inhibition.
Int J Oncol
; 56(6): 1429-1441, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236593
10.
Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF.
Front Immunol
; 11: 1147, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32582212
11.
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.
Cancer Cell
; 38(6): 829-843.e4, 2020 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33157050
12.
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
J Transl Med
; 7: 35, 2009 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19457253
13.
A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression.
J Transl Med
; 6: 6, 2008 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-18221542
14.
Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
Int J Oncol
; 32(3): 633-41, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18292941
15.
Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer.
Mol Cancer Ther
; 17(5): 897-907, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483214
16.
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
J Transl Med
; 5: 19, 2007 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17448240
17.
In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.
Oncol Rep
; 37(3): 1367-1378, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28098866
18.
Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release.
Front Immunol
; 8: 1342, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29109725
19.
Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study.
Front Immunol
; 8: 625, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28620382
20.
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.
Cancer Cell
; 31(2): 225-239, 2017 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28196595